MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 3 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $40.22 (0.25% upside)

Analysts' Ratings History for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetActions
9/1/2015RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Citigroup Inc.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Leerink SwannReiterated RatingOutperform$40.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015RBC CapitalBoost Price TargetOutperform$39.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2015JPMorgan Chase & Co.Reiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015Jefferies GroupUpgradeHold -> Buy$29.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015Leerink SwannBoost Price TargetOutperform$35.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015GuggenheimReiterated RatingBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015OppenheimerReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015MizuhoUpgradeNeutral -> Buy$28.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015RBC CapitalReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Leerink SwannBoost Price TargetOutperform$33.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015GuggenheimSet Price TargetBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015RBC CapitalReiterated RatingOutperform$38.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JPMorgan Chase & Co.Boost Price TargetOverweight$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannLower Price TargetOutperform$35.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Citigroup Inc.Set Price TargetHold$30.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015MizuhoLower Price TargetNeutral$30.00 -> $27.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Citigroup Inc.Initiated CoverageNeutral$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015MizuhoInitiated CoverageNeutral$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Citigroup Inc.Boost Price TargetNeutral$27.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2015Leerink SwannUpgradeMarket Perform -> Outperform$24.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseUpgradeNeutral -> Outperform$27.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Credit SuisseReiterated RatingNeutral$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014Citigroup Inc.Reiterated RatingNeutral$30.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2014Credit SuisseReiterated RatingNeutral$28.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014Credit SuisseDowngradeOutperform -> Neutral$45.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2013Leerink SwannReiterated RatingOutperform$40.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha